0001477932-15-007264.txt : 20151120 0001477932-15-007264.hdr.sgml : 20151120 20151120151604 ACCESSION NUMBER: 0001477932-15-007264 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20151118 ITEM INFORMATION: Termination of a Material Definitive Agreement FILED AS OF DATE: 20151120 DATE AS OF CHANGE: 20151120 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Biotech Products Services & Research, Inc. CENTRAL INDEX KEY: 0001557376 STANDARD INDUSTRIAL CLASSIFICATION: MISCELLANEOUS TRANSPORTATION EQUIPMENT [3790] IRS NUMBER: 474180540 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-55008 FILM NUMBER: 151246419 BUSINESS ADDRESS: STREET 1: 4045 SHERIDAN AVENUE STREET 2: SUITE 239 CITY: MIAMI STATE: FL ZIP: 33140 BUSINESS PHONE: 305-370-0482 MAIL ADDRESS: STREET 1: 4045 SHERIDAN AVENUE STREET 2: SUITE 239 CITY: MIAMI STATE: FL ZIP: 33140 FORMER COMPANY: FORMER CONFORMED NAME: BESPOKE TRICYCLES INC DATE OF NAME CHANGE: 20120831 8-K 1 bpsr_8k.htm FORM 8-K bpsr_8k.htm

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION 

WASHINGTON, DC 20549

 

FORM 8-K

 

CURRENT REPORT PURSUANT 

TO SECTION 13 OR 15(D) OF THE 

SECURITIES EXCHANGE ACT OF 1934

 

Date of report (Date of earliest event reported): November 18, 2015

 

BIOTECH PRODUCTS SERVICES AND RESEARCH, INC.

(Exact Name of Registrant as Specified in Its Charter)

 

Nevada

(State or Other Jurisdiction of Incorporation)

 

000-55008

 

47-4180540

(Commission File Number)

 

(IRS Employer Identification No.)

 

4045 Sheridan Avenue, Suite 239 

Miami, Florida 33140 

(Address of Principal Executive Offices, Zip Code)

 

(305)-370-0482 

(Registrant's Telephone Number, Including Area Code)

 

-----------------------------------------------------------------------

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 

Section 1 – Registrant's Business and Operations

 

Item 1.02 Termination of a Material Definitive Agreement.

 

On November 17, 2015, each of Biotech Products Services and Research, Inc. (the "Company"), BD Source and Distribution Corp., a Florida corporation ("BD Source") and wholly-owned subsidiary of the Company, Brian May and Dana Johnson executed a Termination Agreement and Mutual Release. The parties released each other from any claims or liabilities one to the other, and the employment agreements between BD Source and each of Mr. May and Ms. Johnson were terminated in their entirety. See the Current Report on Form 8-K dated August 11, 2015 filed by the Company with the Securities and Exchange Commission on September 4, 2015 regarding their employment agreements. As a result of the execution and delivery of said agreement, Mr. May and Ms. Johnson are no longer officers of BD Source and have no further affiliation with the Company.

 

 
2
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

BIOTECH PRODUCTS SERVICES AND RESEARCH, INC.

 

    
Date: November 20, 2015By:/s/ Albert Mitrani

 

 

Name:

Albert Mitrani

 

 

Title:

President and Chief Executive Officer

 

 

 

3